Učitavanje...
Metastatic breast cancer: Endocrine therapy landscape reshaped
Endocrine therapy (ET) of hormone receptor (HR)-positive and human epidermal growth factor receptor 2-(HER2)-negative metastatic breast cancer (MBC) historically focused on estrogen deprivation and antagonism. The identification of several intracellular pathways promoting resistance to antiestrogen...
Spremljeno u:
| Izdano u: | Avicenna J Med |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Medknow Publications & Media Pvt Ltd
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5655644/ https://ncbi.nlm.nih.gov/pubmed/29119080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ajm.AJM_20_17 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|